摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(Dimethylamino)naphthalene-1-sulfonic acid | 30644-36-1

中文名称
——
中文别名
——
英文名称
2-(Dimethylamino)naphthalene-1-sulfonic acid
英文别名
——
2-(Dimethylamino)naphthalene-1-sulfonic acid化学式
CAS
30644-36-1
化学式
C12H13NO3S
mdl
——
分子量
251.3
InChiKey
TYCDGIBDMITBCH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    66
  • 氢给体数:
    1
  • 氢受体数:
    4

文献信息

  • [EN] COMPOUNDS USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES<br/>[FR] COMPOSÉS UTILES DANS LE TRAITEMENT DE MALADIES NÉOPLASIQUES
    申请人:UNIVERSITÄT ZU KÖLN
    公开号:WO2015044177A1
    公开(公告)日:2015-04-02
    The present invention refers to compounds of formula: (formula A), wherein R1 is selected from (formula I), (formula II), (formula (III), (formula IV), (formula V), or (formula B), and wherein R2, R3, R4 and R5 are as defined in the claims and X is OTBS, hydroxy, formyloxy, acetoxy, nitrooxy, nitrooxymethyl, or a halogen; and pharmaceutically acceptable salts thereof, which are useful in the treatment of neoplastic or proliferative disorders, a pharmaceutical composition comprising such a compound and a method preparing this compound.
    本发明涉及以下式的化合物:(式A),其中R1从(式I),(式II),(式III),(式IV),(式V)或(式B)中选择,并且其中R2,R3,R4和R5如权利要求中定义的那样,X为OTBS,羟基,甲酰氧基,乙酰氧基,硝基氧基,硝基甲氧基或卤素;及其药学上可接受的盐,用于治疗肿瘤性或增生性疾病,包括这种化合物的药物组合物和制备该化合物的方法。
  • [EN] SULFONAMIDE SUBSTITUTED XANTHINE DERIVATIVES FOR USE AS PEPCK INHIBITORS<br/>[FR] DERIVES DE XANTHINE SUBSTITUES PAR DES SULFONAMIDES ET UTILES COMME INHIBITEURS DE PEPCK
    申请人:HOFFMANN LA ROCHE
    公开号:WO2004074288A1
    公开(公告)日:2004-09-02
    The present invention is concerned with sulfonamide substituted xanthine derivatives of formula (I) or a pharmaceutically acceptable salts or prodrugs thereof, wherein R1, R2 and R3 are as defined in the specification. Compounds of formula (I) and pharmaceutically acceptable salts or prodrugs thereof show activity as modulators of gluconeogenesis.
    本发明涉及式(I)的磺酰胺取代的黄嘌呤生物或其药用可接受的盐或前药,其中R1、R2和R3如说明书中所定义。式(I)的化合物及其药用可接受的盐或前药作为糖异生调节剂显示出活性。
  • Reagents and methods for direct labeling of nucleotides
    申请人:Naleway John J.
    公开号:US20130150254A1
    公开(公告)日:2013-06-13
    The present invention provides systems and methods for production of activatable diazo-derivatives for use in labeling nucleotides. Labeling nucleotides is accomplished by contacting a stable hydrazide derivative of a detectable moiety with an activating polymer reagent which is used to directly label the nucleotide sample. Labeling occurs on the phosphate backbone of the nucleotide which does not perturb hybridization of the labeled nucleotide with its anti-sense strand. Since the method involves direct labeling, all types of nucleotides can be labeled without prior amplification or alteration.
    本发明提供了用于生产可激活重氮衍生物以用于标记核苷酸的系统和方法。通过将可检测基团的稳定的生物与用于直接标记核苷酸样品的活化聚合物试剂接触来完成核苷酸的标记。标记发生在核苷酸的磷酸骨架上,不会干扰标记核苷酸与其反义链的杂交。由于该方法涉及直接标记,所有类型的核苷酸都可以在不经过扩增或改变的情况下进行标记。
  • FREE CHOLESTEROL ANALOGS BEARING A BORON DIPYRROMETHENE DIFLUORO (BODIPY) FLUOROPHORE IN THE SIDE CHAIN AND METHOD OF PREPARATION AND USE THEREOF
    申请人:Bittman Robert
    公开号:US20080177059A1
    公开(公告)日:2008-07-24
    The present invention relates to free cholesterol analogs bearing a boron dipyrromethene difluoro (BODIPY) fluorophore in the side chain and methods of preparation. The compounds of the present invention can be used in fluorescence spectroscopy and fluorescence microscopy to visualize the exchange, distribution, and trafficking of free cholesterol between living cells and to monitor the movement of free cholesterol between ordered and disordered lipid domains in membranes.
    本发明涉及带有吡咯甲烷(BODIPY)荧光团的游离胆固醇类似物及其制备方法。本发明的化合物可用于荧光光谱学和荧光显微镜技术,以可视化活细胞之间游离胆固醇的交换、分布和转运,并监测游离胆固醇在膜中有序和无序脂质域之间的运动。
  • REAGENTS FOR LABELLING NUCLEIC ACIDS AND USES THEREOF
    申请人:Mouritzen Peter
    公开号:US20090023594A1
    公开(公告)日:2009-01-22
    The present invention relates to labelling kits containing novel non-natural nucleotide monomers and to methods of making and using such compounds. The invention further relates to a method of detecting the presence of a nucleic acid, e.g., RNA, of interest in a sample, the method having the following steps: providing the sample; ligating a nucleic acid of interest with a labelling reagent according to the instant invention; providing a nucleic acid array having probes directed to the nucleic acid of interest; hybridizing the labelled nucleic acid fragments to said nucleic acid array; and determining the extent of hybridization to said probes to determine the presence of the nucleic acid of interest.
    本发明涉及包含新型非自然核苷酸单体的标记试剂盒以及制备和使用这些化合物的方法。本发明还涉及一种检测样品中感兴趣的核酸(例如RNA)存在的方法,该方法包括以下步骤:提供样品;使用本发明的标记试剂将感兴趣的核酸连接起来;提供具有针对感兴趣的核酸的探针的核酸阵列;将标记的核酸片段杂交到该核酸阵列上;并确定杂交到探针的程度以确定感兴趣的核酸是否存在。
查看更多